Svetlana Mojsov, one of the Scientists behind Ozempic, and Mathematician Carlos Kenig, who Decoded Laws of Motion, Honored as King Faisal Prize 2026 Laureates
This image was generated by AI and may not depict real events.
The King Faisal Prize 2026 laureates, Professor Svetlana Mojsov and Professor Carlos Kenig, were honored for their groundbreaking work in medicine and mathematics. Mojsov's research on GLP-1 led to the development of obesity treatments, while Kenig's work on nonlinear partial differential equations has far-reaching applications.
The King Faisal Foundation honored two scientists for their pioneering work. Professor Svetlana Mojsov, a biochemist, was awarded the Medicine Prize for her research on the hormone GLP-1, which laid the foundation for obesity treatments like Ozempic. Her work has had a significant impact on public health, with hundreds of millions of people worldwide benefiting from the therapies her discoveries enabled. Professor Carlos Kenig, a mathematician, received the Science Prize in Mathematics for his work on nonlinear partial differential equations, which govern phenomena like ocean waves and medical scans. Kenig's research has made complex mathematical problems solvable and useful. The King Faisal Prize ceremony coincided with the 50th anniversary of the King Faisal Foundation.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.